Cannara to Host Investor Webcast on February 19th, 2026

Cannara Biotech Inc. (TSXV: LOVE, OTCQX: LOVFF, FRA: 8CB0), a prominent vertically integrated cannabis producer in Canada, has announced an upcoming investor webcast scheduled for February 19, 2026, at 2:00 PM ET. The event aims to provide insights into the company's operations and future direction. Led by CFO Nicholas Sosiak, the presentation will cover essential aspects of Cannara's business, highlighting its commitment to offering premium-grade cannabis products at competitive prices from its expansive facilities located in Québec, which span over 1.6 million square feet.

Investors attending the webcast will have the chance to engage with the management team during an interactive Q&A session following the presentation. This format encourages active participation and allows stakeholders to voice their queries regarding the company's strategic initiatives and market outlook. Interested individuals can pre-register for the live event via a designated link provided in the announcement.

Cannara's state-of-the-art facilities enable a potential annual cultivation output of 100,000 kg, benefiting from Québec's advantageous low electricity costs, which significantly contribute to the affordability of its premium products. The upcoming webcast represents an opportunity for investors and analysts to gain deeper insights into Cannara’s business strategies and operational efficiencies, reinforcing the company's position within the evolving cannabis industry.

For those unable to attend the live event, an archived version of the webcast will be made available on Cannara’s investor relations website. As Cannara continues to expand its footprint in the Canadian cannabis market, the investor webcast provides a platform for transparency and investor engagement.

As Cannara Biotech Inc. prepares to host its investor webcast on February 19, 2026, investors should approach this event strategically, considering the company’s robust operational framework and market dynamics.

Cannara, trading under the symbols TSXV: LOVE and OTCQX: LOVFF, is positioned favorably within the cannabis sector, primarily due to its extensive facilities in Québec totaling over 1.6 million square feet. This expansive footprint underlines the company's capacity to achieve significant economies of scale, crucial for maintaining affordability in premium cannabis products—a critical factor in a highly competitive market. The emphasis on leveraging lower electricity costs in Québec adds another layer of operational efficiency, strengthening Cannara's competitive edge.

During the upcoming webcast, CFO Nicholas Sosiak will likely address key business metrics, recent developments, and future strategic initiatives. This presentation represents an opportunity for investors to gauge Cannara's trajectory amidst evolving market conditions, regulatory landscapes, and consumer preferences. Potential topics for consideration during the Q&A session could include Cannara's plans for diversifying its product portfolio, enhancing distribution channels, and addressing any potential challenges in the Canadian cannabis market.

Investors should also consider Cannara's stock performance relative to peers in the market. As the cannabis sector matures, the focus has shifted towards profitability and sustainable growth strategies. Analytical review of Cannara's financial health, including recent earnings, cash flow statements, and market positioning, will be crucial in making informed investment decisions.

In summary, those looking to invest in Cannara Biotech should pay close attention to the upcoming webcast, as it will provide vital insights into the company's operational strategies and market positioning. Engaging actively during the Q&A can also provide investors with clarity on key issues affecting their investment outlook.